Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 284, Issue 4 53-4, 2003, Pages

  Hou, Xin ^a   Gobeil Jr , Fernand ^a   Marrache, Anne Marilise ^a,b   Quiniou, Christiane ^a   Brault, Sonia ^a,b   Checchin, Daniella ^a,b   Bernier, Sylvie G ^a   Sennlaub, Florian ^a   Joyal, Jean Sebastien ^a   Abran, Daniel ^c   Peri, Krishna ^c   Varma, Daya R ^b   Chemtob, Sylvain ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Theratechnologies Inc   (Canada)

Author keywords

Age dependence; Ischemia; Peroxidation; Thromboxane

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM CHANNEL BLOCKING AGENT; INOSITOL PHOSPHATE; THROMBOCYTE ACTIVATING FACTOR; THROMBOXANE SYNTHASE; TRITIUM;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; ENDOTHELIUM; FETUS; IMMUNOREACTIVITY; MICROVASCULATURE; NEWBORN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PEROXIDATION; PRIORITY JOURNAL; RECEPTOR DENSITY; SWINE; VASOCONSTRICTION;

EID: 0037383133     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00633.2002     Document Type: Article

References (43)

1. Abran D, Varma DR, and Chemtob S. Increased thromboxane-mediated contractions of retinal vessels of newborn pigs to peroxides. Am J Physiol Heart Circ Physiol 268: H628-H632, 1995.
2. Abran D, Varma DR, Li DY, and Chemtob S. Reduced responses of retinal vessels of the newborn pig to prostaglandins but not to thromboxane. Can J Physiol Pharmacol 72: 168-173, 1994.
3. 2-catalyzed arachidonic acid liberation by low dose tert-butyl hydroperoxide without an influence on the enzyme activity in rabbit platelets. Biochem Mol Biol Int 43: 799-806, 1997.
4. Akisu M, Kultursay N, Coker I, and Huseyinov A. Plateletactivating factor is an important mediator in hypoxic ischemic brain injury in the newborn rat. Flunarizine and Ginkgo biloba extract reduce PAF concentration in the brain. Biol Neonate 74: 439-444, 1998.
5. Armstead WM, Pourcyrous M, Mirro R, Leffler CW, and Busija DW. Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. Circ Res 62: 1-7, 1988.
6. Blank ML, Lee T, Fitzgerald V, and Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem 256: 175-178, 1981.
7. 2. Nature 390: 622-625, 1997.
8. Chao W and Olson MS. Platelet-activating factor: receptors and signal transduction. Biochem J 292: 617-629, 1993.
9. Chemtob S, Guest I, Potvin W, and Varma DR. Ontogeny of responses of rabbit aorta to atrial natriuretic factor and isoproterenol. Dev Pharmacol Ther 16: 108-115, 1991.
10. Clavijo LC, Carter MB, Matheson PJ, Wills-Frank LA, Wilson MA, Wead WB, and Garrison RN. Platelet-activating factor and bacteremia-induced pulmonary hypertension. J Surg Res 88: 173-180, 2000.
11. Dillon PK, Ritter AB, and Duran WN. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action. Circ Res 62: 722-731, 1988.
12. 2. J Pharmacol Exp Ther 291: 627-633, 1999.
13. Edwards RM, Trizna W, and Feuerstein G. Platelet-activating factor (PAF) has no direct effect on rat intracerebral arterioles in vitro. J Lipid Mediators 3: 161-165, 1991.
14. Fern R. Intracellular calcium and cell death during ischemia in neonatal rat white matter astrocytes in situ. J Neurosci 18: 7232-7243, 1998.
15. Fox JA. Novel omega-conopeptides reduced field potential amplitudes in the rat hippocampal slice. Neurosci Lett 165: 157-160, 1994.
16. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 260: 3440-3450, 1985.
17. Harper SL, Bohlen HG, and Rubin MJ. Arterial and microvascular contributions to cerebral cortical autoregulation in rats. Am J Physiol Heart Circ Physiol 246: H17-H24, 1984.
18. Himmel HM, Whorton AR, and Strauss HC. Intracellular calcium, currents, and stimulus-response coupling in endothelial cells. Hypertension 21: 112-127, 1993.
19. Hoffman SW, Moore S, and Ellis EF. Isoprostanes: free radical-generated prostaglandins with constrictor effects on cerebral arterioles. Stroke 28: 844-849, 1997.
20. 2α) in immature pig periventricular brain microvessels. Stroke 31: 516-524, 2000.
21. Hughes AD. Calcium channels in vascular smooth muscle cells. J Vasc Res 32: 353-370, 1995.
22. Kinn JW and Bache RJ. Effect of platelet activation on coronary collateral blood flow. Circulation 98: 1431-1437, 1998.
23. 2 effects on cerebral prostanoids and pial arteriolar diameter in piglets. Am J Physiol Heart Circ Physiol 258: H1382-H1387, 1990.
24. 2α receptor density in brain microvessels of pigs. Br J Pharmacol 112: 59-64, 1994.
25. Liu XH, Eun BL, Silverstein FS, and Barks JD. The platelet-activating factor antagonist BN 52021 attenuates hypoxic-ischemic brain injury in the immature rat. Pediatr Res 40: 797-803, 1996.
26. 2 in radical production during ischemia and reperfusion of the rat brain. Brain Res 709: 296-302, 1996.
27. McDonough W, Tran N, Giese A, Norman SA, and Berens ME. Altered gene expression in human astrocytoma cells selected for migration. I. Thromboxane synthase. J Neuropathol Exp Neurol 57: 449-455, 1998.
28. Ment LR, Stewart WB, Petroff OA, and Duncan CC. Thromboxane synthesis inhibitor in a beagle pup model of perinatal asphyxia. Stroke 20: 809-814, 1989.
29. Merritt JE, Armstrong WP, Benham CD, Hallam TJ, Jacob R, Jaxa-Chamiec A, Leigh BK, McCarthy SA, Moores KE, and Rink TJ. SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. Biochem J 271: 515-522, 1990.
30. Montrucchio G, Alloatti G, and Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev 80:1669-1699, 2000.
31. Murphy S, Pearce B, Jeremy J, and Dandona P. Astrocytes as eicosanoid-producing cells. Glia 1: 241-245, 1988.
32. + channels in endothelium-dependent vasodilation produced by hypercapnia in rat mesenteric vascular beds. Br J Pharmacol 125: 168-174, 1998.
33. Peri K, Hardy P, Li DY, Varma DR, and Chemtob S. Prostaglandin G/H synthase-2 is a major contributor of brain prostaglandins in the newborn. J Biol Chem 270: 24615-24620, 1995.
34. Porter JT and McCarthy KD. Hippocampal astrocytes in situ respond to glutamate released from synaptic terminals. J Neurosci 16: 5073-5081, 1996;
35. Predescu D, Ihida K, Predescu S, and Palade GE. The vascular distribution of the platelet-activating factor receptor. Eur J Cell Biol 69: 86-98, 1996.
36. Rivier J, Galyean R, Gray WR, Azimi-Zonooz A, McIntosh JM, Cruz LJ, and Olivera BM. Neuronal calcium channel inhibitors. Synthesis of omega-conotoxin GVIA and effects on 45Ca uptake by synaptosomes. J Biol Chem 262: 1194-1198, 1987.
37. Sano K, Asano T, Tanishima T, and Sasaki T. Lipid peroxidation as a cause of cerebral vasospasm. Neurol Res 2: 253-272, 1980.
38. Sullivan JL. Iron, plasma antioxidants, and the oxygen redical disease of prematurity. Am J Dis Child 142: 1341-1344, 1988.
39. Toda N and Hayashi S. Age-dependent alteration in the response of isolated rabbit basilar arteries to vasoactive agents. J Pharmacol Exp Ther 211: 716-721, 1979.
40. Tran QK, Ohashi K, and Watanabe H. Calcium signalling in endothelial cells. Cardiovasc Res 48: 13-22, 2000.
41. Vannucci RC and Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy. Pediatrics 100:1004-1014, 1997.
42. Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol 5: 135-151, 1998.
43. 2+ channels in reactive astrocytes after brain injury, hypomyelination, and ischemia. J Neurosci 18: 2321-2334, 1998.